We have written in the past about the U.S. regulatory hurdles that have prevented us from carrying many of Japan's most popular sunscreens at Rei Cosmetics.
That may soon begin to change.
The U.S. Food and Drug Administration's (FDA) recent approval of bemotrizinol (BEMT) as a permitted active ingredient in over-the-counter sunscreens marks the first addition to the U.S. sunscreen monograph in more than 20 years. This decision represents a significant shift in the American sunscreen market and could create new opportunities for Japanese cosmetics companies that have long been leaders in sunscreen innovation.
What Is Bemotrizinol?
Bemotrizinol, also known as Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (BEMT) or by the trade name Tinosorb S, is a broad-spectrum UV filter widely used throughout Europe and Asia. It provides protection against both UVA and UVB rays, is highly photostable, and has a long history of safe use in sunscreen formulations around the world.
Unlike some older UV filters, bemotrizinol remains stable when exposed to sunlight, helping maintain consistent protection throughout the day. It also allows formulators to create lightweight, elegant textures that consumers enjoy wearing.
Many popular Japanese sunscreens, including those from Bioré UV, Allie, Anessa, and Skin Aqua, rely on bemotrizinol as part of their UV protection systems. Japan approved bemotrizinol (BEMT/Tinosorb S) for sunscreen use in 1999. It has been used in Japanese sunscreens for more than 25 years and became one of the foundational "next-generation" UV filters that helped Japanese manufacturers develop high-protection, lightweight sunscreen formulations.
As a result, a regulatory and quality gap emerged between the U.S. and many other markets. The FDA's approval of bemotrizinol is an important step toward narrowing that gap.
Opportunities for Japanese Cosmetics Companies
Easier Entry into the U.S. Sunscreen Market
Japanese companies have spent decades perfecting sunscreen formulations that combine high UV protection with exceptional cosmetic elegance. The approval of bemotrizinol may make it easier for these companies to develop products specifically for the U.S. market without sacrificing performance.
Rather than relying solely on mineral sunscreens or significantly reformulated products designed around older FDA-approved filters, brands may have greater flexibility to create formulas that more closely resemble their successful Japanese counterparts.
Growing Consumer Awareness of Japanese Sunscreen Technology
The FDA approval has generated significant media attention, with many articles highlighting that bemotrizinol has been used safely in Europe and Asia for decades.
As American consumers learn more about advanced UV filters, interest in Japanese sunscreen technology is likely to grow. This creates an opportunity for Japanese beauty brands to educate consumers about the science and innovation behind their products while reinforcing Japan's reputation as a global leader in sun protection.
Expansion Beyond Cross-Border E-Commerce
Historically, many Japanese sunscreen brands reached U.S. consumers primarily through cross-border e-commerce channels due to regulatory limitations.
If more Japanese-style sunscreen formulations become compliant with FDA regulations, brands may gain access to a wider range of domestic retail opportunities. This could benefit specialty Japanese beauty retailers like Rei Cosmetics while also creating opportunities for broader distribution through mainstream retail channels.
Challenges Remain
While the approval is a major step forward, it does not immediately open the door for every Japanese sunscreen currently sold overseas.
Many Japanese sunscreen formulations contain multiple UV filters that are still not approved for use in U.S. over-the-counter sunscreens. As a result, manufacturers may still need to reformulate products before bringing them to the American market.
In addition, DSM-Firmenich, the company that submitted the approval request, is expected to receive a period of market exclusivity. This could affect how quickly other brands are able to incorporate bemotrizinol into products sold in the United States. Industry experts expect it may take time before consumers see widespread availability of new formulations.
Looking Ahead
The FDA's approval of bemotrizinol is one of the most significant developments in the U.S. sunscreen industry in decades.
Perhaps even more importantly, the decision signals a willingness to modernize sunscreen regulations and could pave the way for additional UV filter approvals in the future. Industry observers and consumers alike are hopeful that other advanced UV filters commonly used in Japan may eventually follow.
For Japanese cosmetics companies, the approval represents both validation of technologies they have relied on for years and a potential pathway to greater growth in the United States.
As regulations continue to evolve, Japanese beauty brands are well-positioned to lead the next generation of sunscreen innovation, bringing consumers the lightweight textures, advanced UV protection, and high-performance formulas that have made J-Beauty sunscreens so popular around the world.
For those of us in the J-Beauty industry, this may be the beginning of a new era of opportunity in the United States.